UPDATE: Boston Scientific (BSX) Beats Q1 EPS by 2c; Boosts FY14 Profit Outlook - Correct

(Updated - April 29, 2014 9:38 AM EDT)

Boston Scientific Corp. (NYSE: BSX) reported Q1 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.8 billion.

Boston Scientific Corp. sees FY2014 EPS of $0.77-$0.82, versus prior guidance of $0.75-$0.8 and the consensus of $0.78.

Boston Scientific Corp. sees Q2 2014 EPS of $0.18-$0.20, versus the consensus of $0.2. Boston Scientific Corp. sees Q2 2014 revenue of $1.84-1.89 billion, versus the consensus of $1.87 billion.

For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
• Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
• ManpowerGroup (MAN) Tops Q1 EPS by 3c